STOCK TITAN

VREX files 8-K furnishing FY 2025 preliminary results press release

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Varex Imaging Corporation (VREX) filed a current report to announce that it has released a press release with its preliminary operating results for the twelve months ended October 3, 2025. The press release, titled “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025,” is furnished as Exhibit 99.1 to the report and provides details on the company’s fourth quarter and full fiscal year 2025 performance. The company specifies that this information is being furnished under the securities laws rather than formally filed, which affects how it may be used in other regulatory documents.

Positive

  • None.

Negative

  • None.
0001681622false1678 S. Pioneer RoadSalt Lake CityUtah8410400016816222025-11-182025-11-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ___________________________________
FORM 8-K
 ___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2025
  ___________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
 ___________________________________
Delaware
001-37860
81-3434516
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification Number)
1678 S. Pioneer Road, Salt Lake City, Utah
84104
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (801972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockVREXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02Results of Operations and Financial Condition

    On November 18, 2025, Varex Imaging Corporation (the “Company”) issued a press release announcing its preliminary results of operations for the twelve months ended October 3, 2025 entitled: “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025.” A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference into this item.

    This information shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01Financial Statements and Exhibits
    (d)     Exhibits

Exhibit No.Description
99.1
Press Release dated November 18, 2025, entitled "Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025"
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VAREX IMAGING CORPORATION
Dated: November 18, 2025
By:/s/ Matthew A. Martinez
Matthew A. Martinez
Chief Legal Officer and Corporate Secretary


FAQ

What did Varex Imaging Corporation (VREX) disclose in this 8-K?

Varex Imaging Corporation disclosed that it issued a press release announcing its preliminary results of operations for the twelve months ended October 3, 2025, covering its fourth quarter and full fiscal year 2025.

Which period do the preliminary results for VREX cover?

The preliminary results discussed by Varex Imaging Corporation cover the twelve months ended October 3, 2025, which includes its fourth quarter and full fiscal year 2025.

How did Varex Imaging (VREX) provide its FY 2025 financial results?

Varex Imaging provided its FY 2025 financial results through a press release titled “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025,” which is furnished as Exhibit 99.1 to the report.

Is the Varex Imaging (VREX) press release considered filed with the SEC?

No. Varex Imaging states that the information in the press release is furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings, except when specifically referenced.

What exhibits are included with Varex Imaging’s FY 2025 8-K?

The report includes Exhibit 99.1, the press release dated November 18, 2025, titled “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025,” and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document.

Who signed the Varex Imaging Corporation (VREX) 8-K report?

The report was signed on behalf of Varex Imaging Corporation by Matthew A. Martinez, who serves as Chief Legal Officer and Corporate Secretary.
Varex Imaging Corp

NASDAQ:VREX

View VREX Stock Overview

VREX Rankings

VREX Latest News

VREX Latest SEC Filings

VREX Stock Data

470.76M
41.23M
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY